Generic Drugs Market Forecast 2017-2027

Wednesday, January 25, 2017 Drug News
Email Print This Page Comment
Font : A-A+

LONDON, January 25, 2017 /PRNewswire/ --

Growth in Leading Regional and National Markets - US, EU5, Asia-Pacific, Emerging Markets

 

The generic drugs market is expected to grow at a CAGR of 8.8% in the first half of the forecast period and CAGR of 7.0% in the second half of the forecast period. The market is expected to grow at a CAGR of 7.9% from 2015 to 2027. The

market is estimated at $254.6bn in 2016, $384.0bn in 2021, and $574.7bn in 2027.

How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 304-page report you will receive 89 tables and 87 figures- all unavailable elsewhere.

The 303-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope 

• Generic Drugs Market forecasts from 2017-2027

• Generic Drugs National Market forecasts from 2017-2027, covering: - United States - Germany - France - United Kingdom - Italy - Spain - Japan - China - India - Brazil - Russia - South Korea - Turkey - Mexico

• Analysis of the key factors driving and restraining the growth of the generic drugs market from 2017-2027

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

• Assessment of selected leading companies that hold major market shares in the generic drugs market.

Visiongain's study is intended for anyone requiring commercial analyses for the Generic Drugs Market. You find data, trends and predictions.

Buy our report today Generic Drugs Market Forecast 2017-2027: Growth in Leading Regional and National Markets - US, EU5, Asia-Pacific, Emerging Markets.

To request a report overview of this report please emails Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44 (0) 20 7336 6100

Or click on: https://www.visiongain.com/Report/1778/Generic-Drugs-Market-Forecast-2017-2027

List of Companies Mentioned in the Report 

Abbott

AbbVie

Actavis

Alcon (Novartis)

Allergan (Actavis)

Amgen

Anda Inc

APP Pharmaceuticals

Arrow Group (Actavis)

Ascent Pharmahealth (Actavis)

ASKA Pharmaceuticals

Aspen

AstraZeneca

Bergamo (Amgen)

Bioniche Pharma (Mylan)

BMP Sunstone (Sanofi)

CFR Pharmaceuticals (Abbott)

Cipla

Dabur Pharma (Fresenius Kabi)

Daiichi Sankyo

Dalim BioTech

Dr Reddy's Laboratory

Ebewe Pharma (Novartis)

Eden Biopharm Group

Egis

Elder Pharmaceuticals (Torrent Pharmaceuticals)

Eli Lilly

Elyson Pharmaceuticals

EMS Sigma Pharma

Eurofarma Laboratories

Farmacias Similares

Fenwal (Fresenius Kabi)

Forest Laboratories (Actavis)

Foshan Chanbende Development

Fougera Pharmaceuticals (Novartis)

Fresenius Kabi

Fresenius SE & Co

Fuji Pharma

Gedeon Richter

Genfar S.A (Sanofi)

Genzyme (Sanofi)

Gilead Sciences

GlaxoSmithKline (GSK)

Greenstone (Pfizer)

Grupo Sanborns

Grupo Uriach

Hospira (Pfizer)

IDEV Technologies (Abbott)

Ilsung Pharmaceuticals

InnoPharma Inc

Itero Biopharmaceuticals

Janssen

Javelin Pharmaceuticals (Hospira)

Kmart

KMS Pharmaceutical

Kowa Pharmaceuticals

Krka

Labesfal Genéricos (Fresenius Kabi)

Laboratorio Sanderson (Fresenius Kabi)

Laboratorios Best

Laboratorios Kendrick (Sanofi)

Lek (Novartis)

Lupin

Mayne Pharma (Hospira)

Medley (Sanofi)

Merck KGaA

MN Pharma (Amgen)

Momenta Pharmaceuticals

Mylan

Natco Pharma

Nexus Pharmaceuticals

Nichi-Iko

Nippon Chemiphar

Novartis (Sandoz)

Novo Nordisk

OptiMedica (Abbott)

Orchid Chemicals & Pharmaceuticals

Oriel Therapeutics (Novartis)

Parenteral Drugs India Ltd

Perrigo

Pfizer

Piramal (Abbott Laboratories)

Pliva (Teva)

PT Soho Global Health

Ranbaxy (Sun Pharmaceuticals)

Rimsa

Roche

Sabex (Novartis)

Sanofi

Sawai Pharmaceuticals

Schein Pharmaceutical (Actavis)

Shelys (Aspen)

Sigma Pharmaceuticals (Aspen)

Solvay Pharmaceuticals (Abbott)

Specifar Pharmaceuticals (Actavis)

STADA Arzneimittel

Sun Pharma

Synthon

Takeda

Taiyo Pharmaceuticals

Teuto Brasileiro (Pfizer)

Teva

The Laboratory of Analytical Services International Ltd

Towa

UDL Laboratories

Uteron Pharma (Actavis)

Valeant Pharmaceuticals

Wal-Mart

Warner Chilcott (Actavis)

Wockhardt

Wyeth (Pfizer)

Zentiva (Sanofi)

Zhejiang Chiral Medicine Chemicals Co. Ltd

Zhejiang Hisun Pharmaceutical

Zydus Cadila

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

SOURCE Visiongain Ltd



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook